Literature DB >> 16384811

Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease.

Menekse Alpay1, Walter J Koroshetz.   

Abstract

The effect of quetiapine (an atypical antipsychotic with minimal extrapyramidal side effects) on motor as well as behavioral symptoms was studied in five consecutive patients with Huntington's disease in a long-term facility. Improvement of behavioral symptoms (i.e., psychotic symptoms, agitation, irritability, and insomnia) without worsening of motor functioning were noted.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16384811     DOI： 10.1176/appi.psy.47.1.70

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


  29 in total

1.  Therapeutics in Huntington's Disease.

Authors:  Annie Killoran; Kevin M Biglan
Journal:  Curr Treat Options Neurol       Date:  2012-02-08       Impact factor: 3.598

2.  Pallidal neuronal discharge in Huntington's disease: support for selective loss of striatal cells originating the indirect pathway.

Authors:  Philip A Starr; Gail A Kang; Susan Heath; Shoichi Shimamoto; Robert S Turner
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

3.  Treatment of huntington disease.

Authors:  Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

4.  Drug repositioning by integrating target information through a heterogeneous network model.

Authors:  Wenhui Wang; Sen Yang; Xiang Zhang; Jing Li
Journal:  Bioinformatics       Date:  2014-06-27       Impact factor: 6.937

Review 5.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

6.  Psychosis with Huntington's disease: role of antipsychotic medications.

Authors:  Jonathan Ding; Amin Muhammad Gadit
Journal:  BMJ Case Rep       Date:  2014-08-19

Review 7.  Huntington's Disease-Update on Treatments.

Authors:  Kara J Wyant; Andrew J Ridder; Praveen Dayalu
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

Review 8.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

Review 9.  Treatment of Huntington's disease.

Authors:  Samuel Frank
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 10.  Advances in the pharmacological management of Huntington's disease.

Authors:  Samuel Frank; Joseph Jankovic
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.